These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28596972)

  • 41. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The neutrophil in chronic obstructive pulmonary disease.
    Hoenderdos K; Condliffe A
    Am J Respir Cell Mol Biol; 2013 May; 48(5):531-9. PubMed ID: 23328639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4.
    Sabroe I; Jones EC; Whyte MK; Dower SK
    Immunology; 2005 May; 115(1):90-8. PubMed ID: 15819701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advanced Role of Neutrophils in Common Respiratory Diseases.
    Liu J; Pang Z; Wang G; Guan X; Fang K; Wang Z; Wang F
    J Immunol Res; 2017; 2017():6710278. PubMed ID: 28589151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophils in asthma.
    Macdowell AL; Peters SP
    Curr Allergy Asthma Rep; 2007 Nov; 7(6):464-8. PubMed ID: 17986378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Airways inflammation and COPD: epithelial-neutrophil interactions.
    Pettersen CA; Adler KB
    Chest; 2002 May; 121(5 Suppl):142S-150S. PubMed ID: 12010843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease?
    Naylor EJ; Bakstad D; Biffen M; Thong B; Calverley P; Scott S; Hart CA; Moots RJ; Edwards SW
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):135-43. PubMed ID: 17363778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD.
    Kirsten AM; Förster K; Radeczky E; Linnhoff A; Balint B; Watz H; Wray H; Salkeld L; Cullberg M; Larsson B
    Pulm Pharmacol Ther; 2015 Apr; 31():36-41. PubMed ID: 25681277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding the role of neutrophils in chronic inflammatory airway disease.
    Jasper AE; McIver WJ; Sapey E; Walton GM
    F1000Res; 2019; 8():. PubMed ID: 31069060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease.
    Liu T; Wang FP; Wang G; Mao H
    Chin Med J (Engl); 2017 Mar; 130(6):730-736. PubMed ID: 28303858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.
    Ha H; Debnath B; Neamati N
    Theranostics; 2017; 7(6):1543-1588. PubMed ID: 28529637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting defective pulmonary innate immunity - A new therapeutic option?
    Belchamber KBR; Donnelly LE
    Pharmacol Ther; 2020 May; 209():107500. PubMed ID: 32061706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
    Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutrophilic Inflammation in Asthma and Association with Disease Severity.
    Ray A; Kolls JK
    Trends Immunol; 2017 Dec; 38(12):942-954. PubMed ID: 28784414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
    Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation.
    Chen CY; Tsai YF; Chang WY; Yang SC; Hwang TL
    Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27472345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist.
    Seiberling M; Kamtchoua T; Stryszak P; Ma X; Langdon RB; Khalilieh S
    Int Immunopharmacol; 2013 Oct; 17(2):178-83. PubMed ID: 23791619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice.
    Mizutani N; Nabe T; Yoshino S
    J Immunol; 2014 Feb; 192(4):1372-84. PubMed ID: 24446518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tristetraprolin and its role in regulation of airway inflammation.
    Prabhala P; Ammit AJ
    Mol Pharmacol; 2015 Apr; 87(4):629-38. PubMed ID: 25429052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.